Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Oct 16;10(20):4750.
doi: 10.3390/jcm10204750.

The Role of Uric Acid in Acute and Chronic Coronary Syndromes

Affiliations
Review

The Role of Uric Acid in Acute and Chronic Coronary Syndromes

Alessandro Maloberti et al. J Clin Med. .

Abstract

Uric acid (UA) is the final product of the catabolism of endogenous and exogenous purine nucleotides. While its association with articular gout and kidney disease has been known for a long time, new data have demonstrated that UA is also related to cardiovascular (CV) diseases. UA has been identified as a significant determinant of many different outcomes, such as all-cause and CV mortality, and also of CV events (mainly Acute Coronary Syndromes (ACS) and even strokes). Furthermore, UA has been related to the development of Heart Failure, and to a higher mortality in decompensated patients, as well as to the onset of atrial fibrillation. After a brief introduction on the general role of UA in CV disorders, this review will be focused on UA's relationship with CV outcomes, as well as on the specific features of patients with ACS and Chronic Coronary Syndrome. Finally, two issues which remain open will be discussed: the first is about the identification of a CV UA cut-off value, while the second concerns the possibility that the pharmacological reduction of UA is able to lower the incidence of CV events.

Keywords: acute coronary syndrome; chronic coronary syndrome; uric acid.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Mechanisms contributing to the relationship between uric acid and cardiovascular diseases. HTN = Arterial Hypertension; DM = Diabetes Mellitus; CKD = Chronic Kidney Disease; TOD = Target Organ Damage.
Figure 2
Figure 2
Summary of the different uric acid cut-offs according to cardiovascular diseases. CV = Cardiovascular; MI = Myocardial Infarction; HF = Heart Failure.

References

    1. Maloberti A., Giannattasio C., Bombelli M., Desideri G., Cicero A.F.G., Muiesan M.L., Rosei E.A., Salvetti M., Ungar A., Rivasi G., et al. Hyperuricemia and risk of cardiovascular outcomes: The experience of the URRAH (Uric Acid Right for Heart Health) project. High Blood Press. Cardiovasc. Prev. 2020;27:121–128. doi: 10.1007/s40292-020-00368-z. - DOI - PubMed
    1. Meisinger C., Koenig W., Baumert J., Doring A. Uric acid levels are associated with all cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population: The MONICA/KORA cohort study. Arterioscler. Thromb. Vasc. Biol. 2008;28:1186–1192. doi: 10.1161/ATVBAHA.107.160184. - DOI - PubMed
    1. Fang J., Alderman M.H. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971–1992. National Health and nutrition examination survey. JAMA. 2000;283:2404–2410. doi: 10.1001/jama.283.18.2404. - DOI - PubMed
    1. Bos M.J., Koudstaal P.J., HofmaN A., Witteman J.C., Breteler M.M. Uric acid is a risk factor for myocardial infarction and stroke: The Rotterdam study. Stroke. 2006;37:1503–1507. doi: 10.1161/01.STR.0000221716.55088.d4. - DOI - PubMed
    1. Muiesan M.L., Salvetti M., Virdis A., Masi S., Casiglia E., Tikhonoff V., Barbagallo C.M., Bombelli M., Cicero A.F.G., Cirillo M., et al. Serum uric acid, predicts heart failure in a large Italian cohort: Search for a cut-off value the URic acid Right for heArt Health study. J. Hypertens. 2021;39:62–69. doi: 10.1097/HJH.0000000000002589. - DOI - PubMed

LinkOut - more resources